TIM-3: An Emerging Target in the Liver Diseases.
T cell immunoglobulin domain and mucin domain containing molecu le 3 (TIM-3) is found expression in the surface of terminally differentiated T cells and belongs to the TIM family of type I transmembrane proteins. It binds to the ligand Galectin-9 and mediates T cell apoptosis. As the research progresses, TIM-3 is also expressed in Th17, NK, Monocyte, which binds to ligand, and induce immune peripheral tolerance in both mice and man. Numerous researches have demonstrated that TIM-3 influences liver diseases, including liver-associated chronic viral infection, liver fibrosis, liver cancer et al and suggest new approaches to intervention. Currently, targeted therapy of TIM-3 is a new treatment in the field of immunization. Although many studies have proven that TIM-3 has an inhibitory effect in vivo, the specific mechanism is not clear. Herein, we summarize the important role of TIM-3 in the regulation of liver disease and prospects for future clinical research. TIM-3 will provide new targets for improving clinical liver disease. This article is protected by copyright. All rights reserved.